CCAG endorses to is found the <5 day jurisdictions. Further retain the 5 day split. transfer split should be work to be undertaken retained for AR-DRG V9.0 (see Section 2.4.1) 3. Age splits (5 ADRGs) ACCD requested CCAG’s CCAG endorsed: DTG agreed with CCAG Retain Age as a splitting advice as to whether retaining the age endorsements and variable in A07 and A09 Age as a splitting split in A07 requested that Age as a variable should be Allogeneic bone splitting variable be maintained within 2 marrow transplant retained for A07 and ADRGs involving recognising that A09 children (A07, and I13) clinically, these patients are DTG endorsed the different and also removal of Age as a taking into account splitting variable in all that Pre-MDCs are other instances (F19, an area flagged for I13 and U63) review in a future version of the classification removing the age split for I13 Humerus, tibia, fibula and ankle procedures 4. Diagnosis and 4. Diagnosis and 4. Diagnosis and 4. Diagnosis and procedure code splits procedure code splits procedure code splits procedure code splits (23 ADRGs) (23 (23 ADRGs) (23 ADRGs) ACCD requested CCAG’s CCAG endorsed DTG agreed with CCAG Remove diagnosis and advice on ADRGs J06 removing the on endorsement to remove procedure code and J07 in relation to malignancy in J06 as a splitting variables Major malignancy the need to maintain a splitting variable procedures for breast malignancy split disorders and J07 Minor procedures for breast disorders as the split provided no useful information and the costs were similar and not reflective of the types of patients in the DRGs
CCAG endorses to retain the 5 day split. is found the <5 day transfer split should be retained jurisdictions. Further work to be undertaken for AR-DRG V9.0 (see Section 2.4.1) 3. Age splits (5 ADRGs) ACCD requested CCAG’s advice as to whether Age as a splitting variable should be maintained within 2 ADRGs involving children (A07, and I13) CCAG endorsed: retaining the age split in A07 Allogeneic bone marrow transplant recognising that clinically, these patients are different and also taking into account that Pre-MDCs are an area flagged for review in a future version of the classification removing the age split for I13 Humerus, tibia, fibula and ankle procedures DTG agreed with CCAG endorsements and requested that Age as a splitting variable be retained for A07 and A09 DTG endorsed the removal of Age as a splitting variable in all other instances (F19, I13 and U63) Retain Age as a splitting variable in A07 and A09 4. Diagnosis and procedure code splits (23 ADRGs) 4. Diagnosis and procedure code splits (23 4. Diagnosis and procedure code splits (23 ADRGs) 4. Diagnosis and procedure code splits (23 ADRGs) ACCD requested CCAG’s advice on ADRGs J06 and J07 in relation to the need to maintain a malignancy split CCAG endorsed removing the on malignancy in J06 Major procedures for breast disorders and J07 Minor procedures for breast disorders as the split provided no useful information and the costs were similar and not reflective of the types of patients in the DRGs DTG agreed with CCAG endorsement to remove malignancy as a splitting variable Remove diagnosis and procedure code splitting variables